vs
Side-by-side financial comparison of FIRST MID BANCSHARES, INC. (FMBH) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
FIRST MID BANCSHARES, INC. is the larger business by last-quarter revenue ($88.2M vs $47.7M, roughly 1.8× IRONWOOD PHARMACEUTICALS INC). FIRST MID BANCSHARES, INC. runs the higher net margin — 26.8% vs -4.8%, a 31.6% gap on every dollar of revenue. On growth, FIRST MID BANCSHARES, INC. posted the faster year-over-year revenue change (3.4% vs -47.3%). FIRST MID BANCSHARES, INC. produced more free cash flow last quarter ($124.0M vs $74.6M). Over the past eight quarters, FIRST MID BANCSHARES, INC.'s revenue compounded faster (5.0% CAGR vs -20.2%).
First Mid Bancshares Inc. is a U.S.-headquartered regional financial services holding company. It provides full-range retail and commercial banking products, wealth management, insurance solutions, and agricultural financing, mainly serving individual consumers, small and medium-sized enterprises, and agricultural clients across multiple Midwestern states including Illinois, Missouri, and Indiana.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
FMBH vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $88.2M | $47.7M |
| Net Profit | $23.7M | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | 34.0% | 14.3% |
| Net Margin | 26.8% | -4.8% |
| Revenue YoY | 3.4% | -47.3% |
| Net Profit YoY | 23.5% | -200.9% |
| EPS (diluted) | $0.98 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $88.2M | $47.7M | ||
| Q3 25 | $89.3M | $122.1M | ||
| Q2 25 | $87.5M | $85.2M | ||
| Q1 25 | $84.3M | $41.1M | ||
| Q4 24 | $85.3M | $90.5M | ||
| Q3 24 | $80.6M | $91.6M | ||
| Q2 24 | $79.2M | $94.4M | ||
| Q1 24 | $79.9M | $74.9M |
| Q4 25 | $23.7M | $-2.3M | ||
| Q3 25 | $22.5M | $40.1M | ||
| Q2 25 | $23.4M | $23.6M | ||
| Q1 25 | $22.2M | $-37.4M | ||
| Q4 24 | $19.2M | $2.3M | ||
| Q3 24 | $19.5M | $3.6M | ||
| Q2 24 | $19.7M | $-860.0K | ||
| Q1 24 | $20.5M | $-4.2M |
| Q4 25 | 34.0% | 14.3% | ||
| Q3 25 | 32.2% | 61.8% | ||
| Q2 25 | 34.4% | 53.2% | ||
| Q1 25 | 33.4% | -70.7% | ||
| Q4 24 | 29.7% | 34.8% | ||
| Q3 24 | 31.5% | 28.0% | ||
| Q2 24 | 33.7% | 26.5% | ||
| Q1 24 | 33.7% | 14.7% |
| Q4 25 | 26.8% | -4.8% | ||
| Q3 25 | 25.2% | 32.8% | ||
| Q2 25 | 26.8% | 27.7% | ||
| Q1 25 | 26.3% | -90.9% | ||
| Q4 24 | 22.5% | 2.5% | ||
| Q3 24 | 24.2% | 4.0% | ||
| Q2 24 | 24.9% | -0.9% | ||
| Q1 24 | 25.6% | -5.6% |
| Q4 25 | $0.98 | $0.01 | ||
| Q3 25 | $0.94 | $0.23 | ||
| Q2 25 | $0.98 | $0.14 | ||
| Q1 25 | $0.93 | $-0.23 | ||
| Q4 24 | $0.81 | $0.03 | ||
| Q3 24 | $0.81 | $0.02 | ||
| Q2 24 | $0.82 | $-0.01 | ||
| Q1 24 | $0.86 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $215.5M |
| Total DebtLower is stronger | $354.5M | — |
| Stockholders' EquityBook value | $958.7M | $-261.8M |
| Total Assets | $8.0B | $396.9M |
| Debt / EquityLower = less leverage | 0.37× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $215.5M | ||
| Q3 25 | — | $140.4M | ||
| Q2 25 | — | $92.9M | ||
| Q1 25 | — | $108.5M | ||
| Q4 24 | — | $88.6M | ||
| Q3 24 | — | $88.2M | ||
| Q2 24 | — | $105.5M | ||
| Q1 24 | — | $121.5M |
| Q4 25 | $354.5M | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $958.7M | $-261.8M | ||
| Q3 25 | $932.2M | $-264.2M | ||
| Q2 25 | $894.1M | $-308.2M | ||
| Q1 25 | $870.9M | $-334.1M | ||
| Q4 24 | $846.4M | $-301.3M | ||
| Q3 24 | $858.5M | $-311.3M | ||
| Q2 24 | $813.6M | $-321.7M | ||
| Q1 24 | $798.0M | $-330.5M |
| Q4 25 | $8.0B | $396.9M | ||
| Q3 25 | $7.8B | $396.1M | ||
| Q2 25 | $7.7B | $342.9M | ||
| Q1 25 | $7.6B | $327.2M | ||
| Q4 24 | $7.5B | $350.9M | ||
| Q3 24 | $7.6B | $389.5M | ||
| Q2 24 | $7.6B | $395.6M | ||
| Q1 24 | $7.7B | $438.8M |
| Q4 25 | 0.37× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $130.9M | $74.6M |
| Free Cash FlowOCF − Capex | $124.0M | $74.6M |
| FCF MarginFCF / Revenue | 140.6% | 156.3% |
| Capex IntensityCapex / Revenue | 7.8% | 0.0% |
| Cash ConversionOCF / Net Profit | 5.53× | — |
| TTM Free Cash FlowTrailing 4 quarters | $207.9M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $130.9M | $74.6M | ||
| Q3 25 | $33.0M | $47.6M | ||
| Q2 25 | $7.7M | $-15.1M | ||
| Q1 25 | $47.9M | $20.0M | ||
| Q4 24 | $124.4M | $15.2M | ||
| Q3 24 | $33.1M | $9.9M | ||
| Q2 24 | $24.0M | $33.5M | ||
| Q1 24 | $29.0M | $45.0M |
| Q4 25 | $124.0M | $74.6M | ||
| Q3 25 | $31.9M | $47.6M | ||
| Q2 25 | $6.0M | $-15.1M | ||
| Q1 25 | $46.0M | $19.9M | ||
| Q4 24 | $119.5M | — | ||
| Q3 24 | $32.0M | $9.9M | ||
| Q2 24 | $22.9M | $33.4M | ||
| Q1 24 | $27.6M | $44.9M |
| Q4 25 | 140.6% | 156.3% | ||
| Q3 25 | 35.8% | 39.0% | ||
| Q2 25 | 6.8% | -17.7% | ||
| Q1 25 | 54.5% | 48.4% | ||
| Q4 24 | 140.0% | — | ||
| Q3 24 | 39.7% | 10.8% | ||
| Q2 24 | 28.9% | 35.4% | ||
| Q1 24 | 34.5% | 60.0% |
| Q4 25 | 7.8% | 0.0% | ||
| Q3 25 | 1.2% | 0.0% | ||
| Q2 25 | 2.0% | 0.0% | ||
| Q1 25 | 2.3% | 0.1% | ||
| Q4 24 | 5.8% | 0.0% | ||
| Q3 24 | 1.4% | 0.0% | ||
| Q2 24 | 1.4% | 0.1% | ||
| Q1 24 | 1.9% | 0.1% |
| Q4 25 | 5.53× | — | ||
| Q3 25 | 1.47× | 1.19× | ||
| Q2 25 | 0.33× | -0.64× | ||
| Q1 25 | 2.16× | — | ||
| Q4 24 | 6.49× | 6.74× | ||
| Q3 24 | 1.70× | 2.71× | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 1.42× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
